Purchase Order 75N98019P02659

The U.S. Office of Logistics and Acquisition Operations awarded a firm fixed-price purchase order valued at $8,204.62 to Qiagen, LLC for chemicals on December 3, 2024, with an ultimate completion date of December 3, 2026. The award, which carries no set-aside designation, reflects Qiagen's demonstrated capability to compete effectively in the open federal marketplace. Performance will take place at the company's Germantown, Maryland headquarters, where Qiagen maintains substantial operations...

The Office of Logistics and Acquisition Operations awarded a $33,229.90 firm fixed price purchase order to Qiagen, LLC for preventative maintenance and service of onsite laboratory instruments. The contract, which is not set-aside designated, was awarded on April 15, 2026, with an ultimate completion date of April 14, 2027, and will be performed in Bethesda, Maryland. As a child contract under a larger vehicle, this purchase order leverages Qiagen's established position as a preferred supplier...

<p>The Food and Drug Administration awarded a purchase order to Qiagen, LLC for an automated DNA/RNA extraction system with viral nucleic acid kits valued at $37,207.54 on June 15, 2022, with ultimate completion by June 10, 2026. Work is performed in Germantown, Maryland. The procurement was issued under a pre-solicitation posted May 3, 2022 with a closing date of May 10, 2022. The order carries firm fixed price terms with no set-aside designation.</p>

<p>The Office of Logistics and Acquisition Operations awarded a purchase order to Qiagen, LLC for a software license with a ceiling value of $64,093.50 on September 12, 2016, with ultimate completion on September 29, 2020. No set-aside was applied. Performance occurred in Bethesda, Maryland. The order was issued as a firm fixed price transaction for a commercial software product.</p>

<p>The Office of Logisitics and Acquisition Operations issued a purchase order to Qiagen, LLC on August 13, 2018, for IPA LNUL and CLC license maintenance, with a ceiling value of $11,443.25.</p> <p>Performance occurs in Bethesda, Maryland. The order carries an ultimate completion date of March 5, 2019. No set-aside applies. The purchase order is firm fixed price.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>

<p>The NIH Clinical Center issued a purchase order to Qiagen, LLC on June 12, 2018 for $7,808.68 with firm fixed-price pricing and an ultimate completion date of June 20, 2018. Performance is at Bethesda, Maryland. The source does not specify what is being purchased.</p>

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,060.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, for maintenance on laboratory equipment. The contract has a completion date of June 30, 2023 and was awarded on July 1, 2018. Qiagen has provided a range of goods and services to support federal...

<p>The Office of the Administrator issued a purchase order to Qiagen, LLC on June 11, 2026, for DNeasy PowerWater kits valued at $21,009.88 with firm fixed pricing and an ultimate completion date of July 11, 2026. Performance occurs in Germantown, Maryland. The order procures molecular diagnostics and sample preparation supplies supporting federal laboratory and research operations.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $15,500.00 with an award date of March 13, 2020 and ultimate completion date of March 12, 2021. Performance occurs in Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. The specific commodities or services procured are not detailed in the source.</p>